Key result
FDG PET/CT imaging demonstrated diffuse intense FDG uptake with an SUVmax of 19 in the scalp and face, guiding the treatment plan toward chemotherapy to avoid unnecessary surgery and radiotherapy.
Why the study?
Diffuse cutaneous angiosarcomas are rare.
Case Report (n=1)
FDG PET/CT is useful for staging diffuse cutaneous angiosarcoma and guiding treatment decisions.
FDG PET/CT may aid staging of diffuse cutaneous angiosarcoma; leaves open its comparative value in rare skin malignancies.
Diffuse cutaneous angiosarcomas are rare. Herein, we reported FDG PET/CT findings of cutaneous angiosarcoma in a 59-year-old man. FDG PET/CT imaging was performed for staging, showing diffuse intense FDG uptake with an SUVmax of 19 in the scalp and face. Chemotherapy was recommended for this patient because surgery and radiotherapy were not appropriate due to the widespread skin involvement. Our case suggests that cutaneous angiosarcoma can present with diffuse skin involvement, and FDG PET/CT plays an important role in determining the treatment plan to avoid unnecessary surgery and radiotherapy.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2021) conducted a case report in Cutaneous angiosarcoma (n=1). FDG PET/CT imaging was evaluated on FDG uptake. FDG PET/CT imaging demonstrated diffuse intense FDG uptake with an SUVmax of 19 in the scalp and face, guiding the treatment plan toward chemotherapy to avoid unnecessary surgery and radiotherapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: